Spyre Therapeutics, Inc. (SYRE)

73.02 +3.32 (+4.76%) USD  |  NASDAQ  |  Apr 17, 16:00
74.59 +1.57 (+2.15%) After-Hours: 20:00
More

Spyre Therapeutics Quarterly Actual Revenue

Quarterly Actual Revenue Chart

View Quarterly Actual Revenue for SYRE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Quarterly Actual Revenue Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Quarterly Actual Revenue Range, Past 5 Years

View Quarterly Actual Revenue Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Quarterly Actual Revenue Benchmarks

View Quarterly Actual Revenue Benchmarks
Start Trial
Tyra Biosciences, Inc. Upgrade
Replimune Group, Inc. Upgrade
Savara, Inc. Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade
Agios Pharmaceuticals, Inc. Upgrade